Option score median values (range) | |||||
---|---|---|---|---|---|
Benefit criteria | Status quo | Enhanced routine data | Community epidemiology model | Australian cardiovascular disease model | CHD registry |
Hospital activity | 50 (30 to 80) | 70 (50 to 90) | 75 (40 to 90) | 65 (45 to 85) | 80 (35 to 90) |
Primary care activity | 20 ( 5 to 40) | 40 ( 7 to 60) | 60 (30 to 80) | 50 (20 to 85) | 40 (20 to 80) |
Prescribing | 30 (20 to 90) | 50 (30 to 91) | 70 (40 to 92) | 55 (30 to 92) | 60 (35 to 95) |
Socioeconomic impact | 10 ( 2 to 20) | 10 ( 2 to 50) | 10 ( 2 to 70) | 10 ( 2 to 70) | 10 ( 2 to 60) |
Risk factors | 50 (20 to 80) | 50 (25 to 80) | 70 (35 to 90) | 60 (30 to 85) | 60 (25 to 80) |
Prevalence | 40 (10 to 70) | 55 (30 to 80) | 70 (50 to 90) | 58 (30 to 85) | 60 (20 to 95) |
Incidence | 40 ( 5 to 70) | 52 (25 to 75) | 70 (40 to 90) | 52 (15 to 85) | 51 (20 to 95) |
Case registration | 30 ( 5 to 60) | 40 (25 to 65) | 60 (25 to 95) | 50 (25 to 80) | 50 (20 to 90) |
Mortality rates and case fatality | 55 (20 to 80) | 65 (30 to 80) | 80 (50 to 90) | 65 (40 to 90) | 65 (42 to 95) |
Patient function | 5 ( 0 to 10) | 50 (20 to 80) | 70 (30 to 85) | 50 (20 to 80) | 5 ( 0 to 10) |
Quality of life | 5 ( 0 to 10) | 50 (20 to 80) | 70 (30 to 90) | 10 ( 0 to 50) | 10 ( 0 to 40) |
Compatibility for international comparisons | 50 (25 to 90) | 50 (25 to 90) | 70 (50 to 95) | 65 (40 to 95) | 55 (35 to 90) |
Breadth of coverage | 60 (35 to 85) | 60 (40 to 85) | 70 (55 to 95) | 70 (50 to 95) | 65 (50 to 90) |
Frequency | 60 (25 to 75) | 60 (25 to 85) | 70 (63 to 90) | 70 (50 to 80) | 65 (35 to 90) |